1. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity;Ingelman-Sundberg;Pharmacogenomics J 5(1),2005
2. Abraham BK, Adithan C (2001) Genetic polymorphism of CYP2D6. Indian J Pharmacol 33(3): 147-169.
3. Gaedigk A, Blum M, Gaedigk R, Eichelbaum M, Meyer UA (1991) Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am J Hum Genet 48(5): 943-950.
4. CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication;Kohler;Pharmacogenetics 7(6),1997
5. Kagimoto M, Heim M, Kagimoto K, Zeugin T, Mayer UA (1990) Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. J Biol Chem 265(28): 17209-17214.